Tag: FDA

FDA releases COVID-19 update

Editor's Note The Food and Drug Administration (FDA) on June 10 released a COVID-19 update announcing the following actions taken in its response to the pandemic: The FDA and National Institutes of Health have updated the CURE ID crowd-sourcing app to make it easier for healthcare providers to share their…

Read More

By: Judy Mathias
June 11, 2020
Share

FDA reissues EUAs revising types of respirators that can be decontaminated

Editor's Note Citing a response to public health concerns, the Food & Drug Administration (FDA) on June 7 reissued certain emergency use authorizations (EUAs) to specify which respirators are appropriate for decontamination and reuse. The FDA determined that certain respirators should not be decontaminated for reuse by healthcare professionals during…

Read More

By: Judy Mathias
June 9, 2020
Share

FDA accelerates development of COVID-19 prevention, treatment options

Editor's Note The Food & Drug Administration on May 11 took new actions to accelerate the development of novel prevention and treatment options for COVID-19. The agency is providing guidance documents to make the process for submitting applications to initiate studies for new drugs and biological products more efficient. The…

Read More

By: Judy Mathias
May 14, 2020
Share

CMS releases proposed inpatient payment rule for FY 2021

Editor's Note The Centers for Medicare & Medicaid Services (CMS) on May 11 released a proposed rule that increases Medicare inpatient prospective payment system (IPPS) rates by a net of 3.1% in FY 2021, compared to 2020, for acute care hospitals participating in the Hospital Inpatient Quality Reporting Program that…

Read More

By: Judy Mathias
May 13, 2020
Share

OR leaders chart new territory for resuming elective surgery

Elective surgical procedures that were temporarily suspended in mid-March are now on the table—or soon will be—at some US facilities. The ban, announced on March 18 by the Centers for Medicare & Medicaid Services (CMS), was enacted to free up resources for facilities overwhelmed by surges of COVID-19 patients. On…

Read More

By: Elizabeth Wood
May 12, 2020
Share

FDA issues guidance to prevent device shortages during COVID-19 pandemic

Editor's Note The Food & Drug Administration (FDA) on May 6 issued a guidance to implement section 3121 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) as it relates to shortages and potential shortages of medical devices occurring during the COVID-19 pandemic. Manufacturers are required to notify…

Read More

By: Judy Mathias
May 7, 2020
Share

Siemens Healthineers’ COVID-19 assay given approval for use in Europe

Editor's Note European regulators have approved Siemens Healthineers’ molecular Fast Track Diagnostics SARS-CoV-2 Assay, which has 100% specificity and sensitivity. The new assay uses real-time polymerase chain reaction (PCR) to detect ribonucleic acid (RNA) from this virus. The company plans to ship more than 1.3 million tests per month worldwide…

Read More

By: Judy Mathias
April 30, 2020
Share

Triaging OR capacity amid COVID-19: Lessons from the field

Health systems nationwide are examining policies and procedures related to their resources, staffing, and scheduling to prepare for anticipated patient surges due to COVID-19. In late March, I talked with perioperative physicians and administrators from two health systems with rapid increases in COVID-positive cases, which have prompted significant changes in…

Read More

By: Jo Quetsch, MA, RN
April 23, 2020
Share

FDA updates actions taken in response to COVID-19

Editor's Note Among the actions announced April 15 by the Food & Drug Administration (FDA) in response to the COVID-19 pandemic are: Issuance of two new emergency use authorizations (EUAs) for serology tests, to detect for presence of coronavirus antibodies, to Ortho-Clinical Diagnostics, Inc, and Chembio Diagnostic systems, Inc. Issuance…

Read More

By: Judy Mathias
April 16, 2020
Share

FDA encourages recovered COVID-19 patients to donate plasma for development of therapies

Editor's Note The Food & Drug Administration (FDA) on April 16 provided an update on a potential treatment for COVID-19, called convalescent plasma, and encouraged those who have recovered from the coronavirus to donate this antibody-rich plasma to help others fight this disease. Patients who have fully recovered for at…

Read More

By: Judy Mathias
April 16, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat